comunicacio

First clinical trial of a treatment that attacks lung cancer and brain metastasis at the same time

In a phase 2 clinical trial, researchers have observed that this combination allows to carry out global treatment from the beginning, manages to keep metastases stable for 7

First clinical trial of a treatment that attacks lung cancer and brain metastasis at the same time Read More »

IDIBELL participates in EU-funded ONCODIR project to improve colorectal cancer prevention

Led by the Centre for Research and Technology Hellas (CERTH), the project includes 27 complementary partners from different research domains. This initiative integrates cutting-edge research methodologies powered by artificial intelligence to deliver personalized, evidence-based approaches for preventing this type of cancer.

IDIBELL participates in EU-funded ONCODIR project to improve colorectal cancer prevention Read More »

A meta-analysis by IDIBELL and Bellvitge Hospital examines the use of beta-lactam antibiotics in febrile neutropenia

The results of five studies have been reviewed, two of them randomized clinical trials, with a total of 691 episodes of febrile neutropenia. The effects of the use of beta-lactam antibiotics in intermittent infusions have been compared with prolonged infusions.

A meta-analysis by IDIBELL and Bellvitge Hospital examines the use of beta-lactam antibiotics in febrile neutropenia Read More »

New research will look for risk indicators of harmful internet use among adolescents

Dr. Josep Manuel Menchon, group leader at IDIBELL and head of the Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire to address and reduce the risks of harmful Internet use among adolescents.

New research will look for risk indicators of harmful internet use among adolescents Read More »

Maria Eulàlia Juvé and Jordi Adamuz participate in the publication of a nursing mentoring book

The article by Juvé and Adamuz highlights the importance of knowledge of nursing tools and strategies (ATIC and ARES) to improve patient outcomes and the work environment.

Maria Eulàlia Juvé and Jordi Adamuz participate in the publication of a nursing mentoring book Read More »

The IDIBELL educational Tandem with the Institut Bellvitge closes the 2022-23 academic year with the launch of new activities

The participation of Institute students in the IDIBELL sLHam for women scientists, the creation of a new Sant Jordi award or the co-creation of content and activities for the new Biomedicine subject have been the main novelties of the course.

The IDIBELL educational Tandem with the Institut Bellvitge closes the 2022-23 academic year with the launch of new activities Read More »

Another year at IDIBELL we maintain our commitment to research, training and innovation to improve people’s health

In 2022, with almost 1,500 published articles, of which almost 600 were led by IDIBELL researchers, our research maintained its high level of quality and excellence, with an average impact factor greater than nine.

Another year at IDIBELL we maintain our commitment to research, training and innovation to improve people’s health Read More »

A study postulates vaginal self-sample and urine as applicable tools for endometrial cancer diagnosis and prognosis

Two studies led by IDIBELL and the Catalan Institute of Oncology show that DNA sequencing in these samples can detect endometrial cancer, which would avoid much more invasive and painful methods.

A study postulates vaginal self-sample and urine as applicable tools for endometrial cancer diagnosis and prognosis Read More »

IDIBELL and CIBER researchers identify a new genetic disease that affects the development of the nervous system and causes liver failure

RINT1 mutations would be causing a deregulation of fat metabolism and intracellular communication of energy production. This is a significant advance in the understanding of this disease, and opens new perspectives for diagnosis and possible treatment in the future.

IDIBELL and CIBER researchers identify a new genetic disease that affects the development of the nervous system and causes liver failure Read More »

Scroll to Top